Company page

Hansa Biopharma Ab

Hansa Biopharma AB is a publicly traded company on the Swedish market under the ticker HNSA, with a market capitalization of approximately 363 million USD. The company focuses on developing innovative therapies for patients with rare diseases and organ transplantation. Hansa Biopharma is dedicated to advancing its research and product pipeline to address unmet medical needs.